286 related articles for article (PubMed ID: 36600005)
1. Advances in the clinical management of uveal melanoma.
Carvajal RD; Sacco JJ; Jager MJ; Eschelman DJ; Olofsson Bagge R; Harbour JW; Chieng ND; Patel SP; Joshua AM; Piperno-Neumann S
Nat Rev Clin Oncol; 2023 Feb; 20(2):99-115. PubMed ID: 36600005
[TBL] [Abstract][Full Text] [Related]
2. [DEVELOPMENT AND CHALLENGES IN TREATMENT OF UVEAL MELANOMA].
Zloto O; Vishnevskia-Dai V; Moisseiev J; Fabian ID
Harefuah; 2018 Feb; 157(2):95-98. PubMed ID: 29484864
[TBL] [Abstract][Full Text] [Related]
3. Uveal melanomas. Conservation treatment.
Munzenrider JE
Hematol Oncol Clin North Am; 2001 Apr; 15(2):389-402. PubMed ID: 11370500
[TBL] [Abstract][Full Text] [Related]
4. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
Shildkrot Y; Wilson MW
Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous and uveal melanoma: two different cancers in therapeutic needs.
Bertolotto C
C R Biol; 2021 Nov; 344(3):219-231. PubMed ID: 35786627
[TBL] [Abstract][Full Text] [Related]
6. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
Livingstone E; Zaremba A; Horn S; Ugurel S; Casalini B; Schlaak M; Hassel JC; Herbst R; Utikal JS; Weide B; Gutzmer R; Meier F; Koelsche C; Hadaschik E; Sucker A; Reis H; Merkelbach-Bruse S; Siewert M; Sahm F; von Deimling A; Cosgarea I; Zimmer L; Schadendorf D; Schilling B; Griewank KG
Br J Dermatol; 2020 Nov; 183(5):928-939. PubMed ID: 32064597
[TBL] [Abstract][Full Text] [Related]
7. [Management of uveal melanomas, guidelines for oncologists].
Mathis T; Cassoux N; Tardy M; Piperno S; Gastaud L; Dendale R; Maschi C; Nguyen AM; Meyer L; Bonnin N; Baillif S; Tick S; Mouriaux F; Jaspart F; Dellis J; Rosier L; Desjardins L; Herault J; Caujolle JP; Thariat J
Bull Cancer; 2018 Oct; 105(10):967-980. PubMed ID: 30217336
[TBL] [Abstract][Full Text] [Related]
8. Metastatic disease from uveal melanoma: treatment options and future prospects.
Carvajal RD; Schwartz GK; Tezel T; Marr B; Francis JH; Nathan PD
Br J Ophthalmol; 2017 Jan; 101(1):38-44. PubMed ID: 27574175
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary Routes in Metastatic Uveal Melanomas Depend on
Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH
Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496
[TBL] [Abstract][Full Text] [Related]
10. Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects.
Baggetto LG; Gambrelle J; Dayan G; Labialle S; Barakat S; Michaud M; Grange JD; Gayet L
Cancer Treat Rev; 2005 Aug; 31(5):361-79. PubMed ID: 15994016
[TBL] [Abstract][Full Text] [Related]
11. Update on Metastatic Uveal Melanoma: Progress and Challenges.
Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
[TBL] [Abstract][Full Text] [Related]
12. Ocular oncology: advances in retinoblastoma, uveal melanoma and conjunctival melanoma.
Vasalaki M; Fabian ID; Reddy MA; Cohen VM; Sagoo MS
Br Med Bull; 2017 Jan; 121(1):107-119. PubMed ID: 28069617
[TBL] [Abstract][Full Text] [Related]
13. Novel Approaches to the Systemic Management of Uveal Melanoma.
Khan S; Carvajal RD
Curr Oncol Rep; 2020 Jul; 22(10):104. PubMed ID: 32725406
[TBL] [Abstract][Full Text] [Related]
14. Pathology and genetics of uveal melanoma.
Griewank KG; Murali R
Pathology; 2013 Jan; 45(1):18-27. PubMed ID: 23222249
[TBL] [Abstract][Full Text] [Related]
15. Ocular melanoma: an overview of the current status.
Jovanovic P; Mihajlovic M; Djordjevic-Jocic J; Vlajkovic S; Cekic S; Stefanovic V
Int J Clin Exp Pathol; 2013; 6(7):1230-44. PubMed ID: 23826405
[TBL] [Abstract][Full Text] [Related]
16. Clinical, Histopathological and Cytogenetic Prognosticators in Uveal Melanoma - A Comprehensive Review.
Berus T; Halon A; Markiewicz A; Orlowska-Heitzman J; Romanowska-Dixon B; Donizy P
Anticancer Res; 2017 Dec; 37(12):6541-6549. PubMed ID: 29187428
[TBL] [Abstract][Full Text] [Related]
17. Uveal melanoma dormancy: an acceptable clinical endpoint?
Blanco PL; Lim LA; Miyamoto C; Burnier MN
Melanoma Res; 2012 Oct; 22(5):334-40. PubMed ID: 22895346
[TBL] [Abstract][Full Text] [Related]
18. Posterior uveal melanoma. The Swedish perspective.
Seregard S
Acta Ophthalmol Scand; 1996 Aug; 74(4):315-29. PubMed ID: 8883543
[TBL] [Abstract][Full Text] [Related]
19. Delayed systemic recurrence of uveal melanoma.
Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of metastatic malignant uveal melanoma].
Jäckel A; Bock M; Deichmann M; Waldmann V; Näher H
Hautarzt; 2001 Feb; 52(2):98-103. PubMed ID: 11244899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
